11 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 11 of 11 clinical reviews.
A clinical deep-dive into off-label finasteride for female pattern hair loss (FPHL): evidence level, dosing protocols, contraindications, and how it compares to approved alternatives.
Off-label finasteride (2.5-5mg) may help postmenopausal women with FPHL; contraindicated in pregnancy due to fetal risk. Results take 12-18 months.
A clinical review of finasteride's off-label use in gender-affirming hormone therapy, including evidence quality, dosing patterns, and safety considerations for transgender patients.
A detailed clinical review of off-label finasteride use in gender-affirming care for transgender women and nonbinary people, covering evidence quality, dosing, side effects, and how it compares to other antiandrogens.
A guide to off-label finasteride use in gender-affirming care, covering mechanism, dosing protocols, evidence quality, safety monitoring, and FDA-approved context.
Finasteride is used off-label for hirsutism in women at 2.5 to 5 mg/day. Learn the dosing protocol, trial evidence, contraindications, and how it compares to spironolactone.
A clinical evidence summary of off-label finasteride use for hirsutism, including trial data, dosing protocols, safety concerns, and how it compares to spironolactone and flutamide.
Finasteride is used off-label for hirsutism in women. Review the clinical trial data, side-effect profile, pregnancy contraindication, dosing, and how it compares to spironolactone.
A guide to off-label finasteride for hirsutism: how it works, what the evidence shows, dosing, monitoring requirements, and contraindications.
Off-label finasteride helped hair density in postmenopausal women at doses above 1 mg; the 1 mg male dose showed no benefit. Contraindicated in pregnancy.
Finasteride isn't FDA-approved for women, but doctors prescribe 1-5mg off-label for female pattern hair loss with strict pregnancy testing and lab monitoring.